Zachary Rome's Net Worth
$246 Thousand
Who is Zachary Rome?
Zachary Rome does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PaxMedica, Inc., and Timber Pharmaceuticals, Inc..
SEC CIK
Zachary Rome's CIK is 0001809611
Past Insider Trading and Trends
2022 was Zachary Rome's most active year for acquiring shares with 2 total transactions. Zachary Rome's most active month to acquire stocks was the month of February. 2023 was Zachary Rome's most active year for disposing of shares, totalling 16 transactions. Zachary Rome's most active month to dispose stocks was the month of February. 2022 saw Zachary Rome paying a total of $793.26 for 158,652 shares, this is the most they've acquired in one year. In 2023 Zachary Rome cashed out on 214,241 shares for a total of $234,249.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PaxMedica, Inc. (PXMD) Snapshot price: $0.4477
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.37% | -4.90K |
$0.69 | -$3,383.76 | 10.24K |
Mar 12
| |||
Form 4
| -5.08% | -811.00 |
$0.48 | -$389.28 | 15.15K |
Jan 29
| |||
Form 4
| -2.20% | -359.00 |
$1.03 | -$369.88 | 15.96K |
Scheduled
|
Nov 27
| ||
Form 4
| -5.55% | -16.30K |
$0.18 | -$3,012.42 | 277.39K |
Scheduled
|
Oct 27
| ||
Form 4
| -8.02% | -25.59K |
$0.48 | -$12,353.95 | 293.69K |
Aug 28 - Aug 30
| |||
Form 4
| -13.54% | -50.00K |
$0.56 | -$27,862.00 | 319.28K |
Aug 21 - Aug 22
| |||
Form 4
| -2.53% | -9.58K |
$0.72 | -$6,871.73 | 369.28K |
Jul 26
| |||
Form 4/A
| -2.47% | -9.58K |
$1.61 | -$15,430.24 | 378.87K |
Apr 26
| |||
Form 4
| -1.61% | -6.27K |
$1.61 | -$10,097.92 | 382.18K |
Apr 26
| |||
Form 4
| +34.67% | 100K |
—
|
—
| 388.45K |
Apr 13
| |||
Form 4
| -10.38% | -33.41K |
$1.47 | -$49,004.22 | 288.45K |
Scheduled
|
Mar 8 - Mar 9
| ||
Form 4
| -10.31% | -36.99K |
$1.60 | -$59,174.16 | 321.86K |
Scheduled
|
Mar 6 - Mar 7
| ||
Form 4
| -6.79% | -26.15K |
$1.91 | -$50,072.99 | 358.85K |
Scheduled
|
Mar 2 - Mar 3
| ||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Timber Pharmaceuticals, Inc. (TMBR) No price found
COO, Executive VP & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 59.7K |
$0.15 | -$4,703.14 | 59.7K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||